Literature DB >> 4930867

Levodopa: alterations in behavior.

F K Goodwin, D L Murphy, H K Brodie, W E Bunney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4930867     DOI： 10.1002/cpt1971122part2383

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  8 in total

Review 1.  Neurochemistry and behavior in man.

Authors:  G S Omenn
Journal:  West J Med       Date:  1976-12

Review 2.  Retinal melatonin and dopamine in seasonal affective disorder.

Authors:  D A Oren
Journal:  J Neural Transm Gen Sect       Date:  1991

Review 3.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

4.  [Differential treatment of Parkinson's disease, with special reference to the possibility of iatrogenic disorders (author's transl)].

Authors:  W Gehlen
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1974-04-09

Review 5.  Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

6.  Unipolar and bipolar depressions-a review.

Authors:  A V Rao
Journal:  Indian J Psychiatry       Date:  1984-04       Impact factor: 1.759

7.  Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies.

Authors:  G Giovannoni; J D O'Sullivan; K Turner; A J Manson; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-04       Impact factor: 10.154

Review 8.  Sexual behavior of the male schizophrenic: the impact of illness and medications.

Authors:  J N Nestoros; H E Lehmann; T A Ban
Journal:  Arch Sex Behav       Date:  1981-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.